The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

A.Zh. Fursova

Novosibirsk State Regional Clinical Hospital;
Novosibirsk State Medical University;
Federal Research Center Institute of Cytology and Genetics — Siberian Branch of the Russian Academy of Sciences

I.F. Nikulich

Novosibirsk State Regional Clinical Hospital;
Novosibirsk State Medical University;
Federal Research Center Institute of Cytology and Genetics — Siberian Branch of the Russian Academy of Sciences

E.I. Dmitrieva

Novosibirsk State Medical University

O.G. Gusarevich

Novosibirsk State Medical University

A.S. Derbeneva

Novosibirsk State Regional Clinical Hospital;
Novosibirsk State Medical University;
Federal Research Center Institute of Cytology and Genetics — Siberian Branch of the Russian Academy of Sciences

M.A. Vasilyeva

Novosibirsk State Regional Clinical Hospital;
Novosibirsk State Medical University

O.S. Kozhevnikova

Federal Research Center Institute of Cytology and Genetics — Siberian Branch of the Russian Academy of Sciences

N.G. Kolosova

Federal Research Center Institute of Cytology and Genetics — Siberian Branch of the Russian Academy of Sciences

Three-year follow-up study of clinical effectiveness of antiangiogenic therapy for neovascular age-related macular degeneration

Authors:

A.Zh. Fursova, I.F. Nikulich, E.I. Dmitrieva, O.G. Gusarevich, A.S. Derbeneva, M.A. Vasilyeva, O.S. Kozhevnikova, N.G. Kolosova

More about the authors

Journal: Russian Annals of Ophthalmology. 2023;139(5): 45‑52

Views: 631

Downloaded: 2


To cite this article:

Fursova AZh, Nikulich IF, Dmitrieva EI, Gusarevich OG, Derbeneva AS, Vasilyeva MA, Kozhevnikova OS, Kolosova NG. Three-year follow-up study of clinical effectiveness of antiangiogenic therapy for neovascular age-related macular degeneration. Russian Annals of Ophthalmology. 2023;139(5):45‑52. (In Russ.)
https://doi.org/10.17116/oftalma202313905145

Recommended articles:
Fari­cimab: from research to clinical practice. Russian Annals of Ophthalmology. 2023;(4):115-120

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.